Failure of favipiravir to treat chronic norovirus infection in a kidney-transplant patient
Transpl Infect Dis
.
2024 Feb;26(1):e14235.
doi: 10.1111/tid.14235.
Epub 2024 Jan 5.
Authors
Amandine Darres
1
2
,
Arnaud Del Bello
1
2
,
Olivier Marion
1
3
,
Xavier de Lamballerie
4
,
Denis Malvy
5
6
,
Jacques Izopet
3
7
8
,
Nassim Kamar
1
3
8
Affiliations
1
Department of Nephrology and Organ Transplantation, Toulouse University Hospital, Toulouse, France.
2
Department of Vascular Biology, Institute of Metabolic and Cardiovascular Diseases (I2MC), Toulouse, France.
3
INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Toulouse, France.
4
Unité des Virus Émergents, INSERM-1207, IRD-190, Aix-Marseille University, Marseille, France.
5
Service des maladies infectieuses et tropicales, CHU de Bordeaux, Bordeaux, France.
6
Inserm UMR 1219, IRD EMR 271, Bordeaux Population Health, Université de Bordeaux, Bordeaux, France.
7
Department of Virology, Toulouse University Hospital, Toulouse, France.
8
Université Toulouse III Paul Sabatier, Toulouse, France.
PMID:
38180288
DOI:
10.1111/tid.14235
No abstract available
Publication types
Letter
MeSH terms
Amides*
Caliciviridae Infections* / drug therapy
Humans
Kidney
Kidney Transplantation* / adverse effects
Norovirus*
Pyrazines*
Substances
favipiravir
Amides
Pyrazines